Ginkgo Bioworks Holdings (DNA) FCF Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -9,366.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,366.00 |
| Dec 31, 2025 | -1,473.00 |
| Sep 30, 2025 | 5,180.00 |
| Jun 30, 2025 | 11,701.00 |
| Mar 31, 2025 | 9,822.00 |
| Dec 31, 2024 | 4,826.00 |
| Sep 30, 2024 | 742.00 |
| Jun 30, 2024 | -9,017.00 |
| Mar 31, 2024 | -11,659.00 |
| Dec 31, 2023 | -2,695.00 |
| Sep 30, 2023 | -10,263.00 |
| Jun 30, 2023 | -3,271.00 |
| Mar 31, 2023 | -12,239.00 |
| Dec 31, 2022 | -3,444.00 |
| Sep 30, 2022 | -2,421.00 |
| Jun 30, 2022 | 5,973.00 |
| Mar 31, 2022 | 14,495.00 |
| Dec 31, 2021 | 13,073.00 |